These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6690011)

  • 21. Correlation of hypercupremia with other acute phase reactants in malignant lymphoma.
    Shah I; Lewkow LM; Khilanani U
    Cancer; 1983 Mar; 51(5):851-4. PubMed ID: 6401595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum copper compared to erythrocyte sedimentation rate as indicator of disease activity in Hodgkin's disease.
    Asbjörnsen G
    Scand J Haematol; 1979 Mar; 22(3):193-6. PubMed ID: 451449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of combination chemotherapy of non-Hodgkin's lymphoma.
    Schein PS; Chabner BA; Canellos GP; Young RD; Berard C; DeVita VT
    Br J Cancer Suppl; 1975 Mar; 2():465-73. PubMed ID: 1101932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Copper and zinc levels in serum from human patients with sarcomas.
    Fisher GL; Byers VS; Shifrine M; Levin AS
    Cancer; 1976 Jan; 37(1):356-63. PubMed ID: 764964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum levels of ceruloplasmin, properdin factor B and copper in lymphoma patients.
    Casamassima A; Addabbo L; Caporusso L; Lorusso V
    Int J Biol Markers; 1991; 6(3):183-7. PubMed ID: 1791312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Gastric lymphomas and pseudolymphomas].
    Chabloz R; Givel JC; Saraga P; Saegesser F
    Helv Chir Acta; 1980 Dec; 47(5):547-53. PubMed ID: 7204076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of sialyltransferase in hypercupraemia of non-Hodgkin's lymphoma.
    Shah I; Chou T; Tapazoglou E; Kessel D
    Scand J Haematol; 1984 Mar; 32(3):332-4. PubMed ID: 6701469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum beta 2-microglobulin in malignant lymphoma.
    Hagberg H; Killander A; Simonsson B
    Cancer; 1983 Jun; 51(12):2220-5. PubMed ID: 6189572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined modality therapy in malignant lymphomas.
    Glatein E; Donaldson SS; Rosenberg SA; Kaplan HS
    Cancer Treat Rep; 1977 Sep; 61(6):1199-207. PubMed ID: 332354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma.
    Gonzalez CL; Medeiros LJ; Jaffe ES
    Am J Clin Pathol; 1991 Jul; 96(1):81-9. PubMed ID: 2069139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase II trial of teniposide (VM 26) in advanced non-Hodgkin's lymphoma, with emphasis on the treatment of elderly patients.
    Tirelli U; Carbone A; Crivellari D; Volpe R; Franchin G; Veronesi A; Galligioni E; Trovò M; Tumolo S; Grigoletto E
    Cancer; 1984 Aug; 54(3):393-6. PubMed ID: 6375853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rosette and blastogenesis inhibition by plasma from Hodgkin's disease and other malignancies. Positive correlation in State I and II Hodgkin's disease.
    Sinclair T; Ezdinli EZ; Boonlayangoor P; Wasser LP; Han T
    Cancer; 1983 Jan; 51(2):238-44. PubMed ID: 6336976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP
    Borchmann P; Haverkamp H; Lohri A; Mey U; Kreissl S; Greil R; Markova J; Feuring-Buske M; Meissner J; Dührsen U; Ostermann H; Keller U; Maschmeyer G; Kuhnert G; Dietlein M; Kobe C; Eich H; Baues C; Stein H; Fuchs M; Diehl V; Engert A
    Lancet Oncol; 2017 Apr; 18(4):454-463. PubMed ID: 28236583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Serum levels of copper and zinc in patients with lung cancer].
    Altavilla G; Adamo V; Alafaci E; Buemi B; Chillemi S; La Scala R; Marabello G; Palmara D
    Minerva Med; 1985 Nov; 76(44):2117-20. PubMed ID: 4069424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of elevated antinuclear antibody test in patients with Hodgkin's and Non-Hodgkin's lymphoma: a single center experience.
    Altintas A; Cil T; Pasa S; Danis R; Kilinc I; Ayyildiz O; Muftuoglu E
    Minerva Med; 2008 Feb; 99(1):7-14. PubMed ID: 18299692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central nervous system relapse in unfavourable-histology non-Hodgkin's lymphoma: is prophylaxis indicated?
    Johnson GJ; Oken MM; Anderson JR; O'Connell MJ; Glick JH
    Lancet; 1984 Sep; 2(8404):685-7. PubMed ID: 6147703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of lymphocytic surface markers and histology in adult non-Hodgkin's lymphoma.
    Bloomfield CD; Kersey JH; Brunning RD; Gajl-Peczalska KJ
    Cancer Treat Rep; 1977 Sep; 61(6):963-70. PubMed ID: 332359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination chemotherapy for advanced non-Hodgkin's lymphomas other than diffuse histiocytic or undifferentiated histologies.
    Anderson KC; Skarin AT; Rosenthal DS; MacIntyre JM; Pinkus GS; Case DC; Leonard RC; Canellos GP
    Cancer Treat Rep; 1984 Nov; 68(11):1343-50. PubMed ID: 6209007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A third generation regimen VACOP-B with or without adjuvant radiotherapy for aggressive localized non-Hodgkin's lymphoma: report from the Italian Non-Hodgkin's Lymphoma Co-operative Study Group.
    Santini G; De Souza C; Aversa S; Patti C; Tedeschi L; Candela M; Olivieri A; Chisesi T; Rubagotti A; Centurioni R; Nardi V; Congiu M; Gennaro M; Truini M;
    Braz J Med Biol Res; 2004 May; 37(5):719-28. PubMed ID: 15107935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histopathologic review of lymphoma cases from the Southwest Oncology Group.
    Jones SE; Butler JJ; Byrne GE; Coltman CA; Moon TE
    Cancer; 1977 Mar; 39(3):1071-6. PubMed ID: 334362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.